During the AGM a shareholder asked why Virbac appeared to hogging the credit for Stelfonta, as there was not even a mention of Qbiotics on the label. It was a query that was swiftly deflected. Perhaps Qbiotics needs to take a lesson from the following, particularly as it is collaborating with Merck
Pandion's secret to moving a $65M Merck offer to a $1.9B done deal in a year? Just keep saying no | FierceBiotech
https://www.fiercebiotech.com/biotech/pandion-s-secret-to-moving-a-65m-merck-offer-to-a-1-9b-done-deal-a-year-just-keep-saying-no
- Forums
- ASX - By Stock
- Qbiotics
During the AGM a shareholder asked why Virbac appeared to...
- There are more pages in this discussion • 952 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online